Dianthus Therapeutics, Inc. (DNTH)
Dianthus Therapeutics Market Cap : 4.978B for Nov. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 5.168B |
| November 12, 2026 | 5.206B |
| November 11, 2026 | 5.027B |
| November 10, 2026 | 5.000B |
| November 09, 2026 | 5.067B |
| November 06, 2026 | 4.843B |
| November 05, 2026 | 4.673B |
| November 04, 2026 | 4.831B |
| November 03, 2026 | 4.656B |
| November 02, 2026 | 4.630B |
| October 30, 2026 | 4.514B |
| October 29, 2026 | 4.532B |
| October 28, 2026 | 4.510B |
| October 27, 2026 | 4.358B |
| October 26, 2026 | 4.347B |
| October 23, 2026 | 4.207B |
| October 22, 2026 | 4.303B |
| October 21, 2026 | 4.280B |
| October 20, 2026 | 4.315B |
| October 19, 2026 | 4.085B |
| October 16, 2026 | 3.950B |
| October 15, 2026 | 4.084B |
| October 14, 2026 | 4.097B |
| October 13, 2026 | 4.251B |
| October 12, 2026 | 4.470B |
| Date | Value |
|---|---|
| October 09, 2026 | 4.514B |
| October 08, 2026 | 4.517B |
| October 07, 2026 | 4.651B |
| October 06, 2026 | 4.680B |
| October 05, 2026 | 4.824B |
| October 02, 2026 | 4.834B |
| October 01, 2026 | 4.840B |
| September 30, 2026 | 4.825B |
| September 29, 2026 | 4.776B |
| September 28, 2026 | 4.813B |
| September 25, 2026 | 4.852B |
| September 24, 2026 | 4.971B |
| September 23, 2026 | 5.120B |
| September 22, 2026 | 5.389B |
| September 21, 2026 | 5.286B |
| September 18, 2026 | 5.305B |
| September 17, 2026 | 5.541B |
| September 16, 2026 | 5.616B |
| September 15, 2026 | 5.741B |
| September 14, 2026 | 5.901B |
| September 11, 2026 | 5.820B |
| September 10, 2026 | 5.660B |
| September 09, 2026 | 5.866B |
| September 08, 2026 | 5.980B |
| September 04, 2026 | 5.924B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Xencor, Inc. | 2.663B |
| ACADIA Pharmaceuticals, Inc. | 3.319B |
| Alnylam Pharmaceuticals, Inc. | 21.38B |
| Anika Therapeutics, Inc. | 174.12M |
| Savara, Inc. | 910.53M |
Market Cap Related Metrics
| PS Ratio | 1678.41 |
| PEG Ratio | -1.546 |
| Price to Book Value | 4.010 |
| Price | 88.42 |
| Earnings Yield | -4.52% |
| PEGY Ratio | -1.546 |